Evidence map›Paper›PMID 42357471›Full record

ArticleMolecules (Basel, Switzerland)2026

Metabolite-Centered Evaluation of Plant-Based Substrates: Integrated Profiling of Short-Chain Fatty Acids (SCFAs) and Neuroactive Compounds with Potential Relevance to the Gut-Brain Axis.

Mustafa Yıldız

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mustafa YıldızFaculty of Engineering and Natural Sciences, Department of Food Engineering, Istanbul Sabahattin Zaim University, 34303 Istanbul, Türkiye.ORCID 0000-0002-8232-5655

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents an integrated metabolite-centered framework for the comparative evaluation of plant-based substrates through the simultaneous profiling of fermentation-associated short-chain fatty acids (SCFAs) and neuroactive compounds within a single in vitro experimental platform. Unlike conventional studies focusing on individual metabolite classes, the present approach combines in vitro gastrointestinal digestion with simplified bacterial fermentation to characterize substrate-dependent metabolic responses under controlled experimental conditions. Concurrent evaluation of SCFA production and neuroactive compound formation enabled multidimensional assessment of fermentation-associated metabolite profiles and their potential biochemical interrelationships. Significant differences (

Indexed as

Brain-Gut AxisFatty Acids, VolatileNeurotransmitter AgentsPlantsFermentationgamma-Aminobutyric AcidMetabolomeFatty Acids, Volatilegamma-Aminobutyric AcidNeurotransmitter Agentsgut–brain axis-associated pathwaysin vitro fermentationmetabolite-centered frameworkneuroactive compoundsplant-based substratesshort-chain fatty acids

Identifiers

PMID42357471
PMCPMC13304880

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.